During the past decade, Louisiana Heart Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Louisiana Heart Center" #1 sponsor was "Amgen" with 3 trials, followed by "AstraZeneca" with 2 trials sponsored, "Bayer" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Louisiana Heart Center" #1 collaborator was "Duke Clinical Research Institute" with 3 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Orion Corporation, Orion Pharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Louisiana Heart Center" are "Atherosclerotic Cardiovascular Disease" (3 trials), "Atrial Fibrillation" (3 trials), "Heart Failure" (3 trials), "Acute Coronary Syndrome" (2 trials) and "ASCVD" (1 trials). Many other conditions were trialed in "Louisiana Heart Center" in a lesser frequency.

Most popular intervention types in "Louisiana Heart Center" are "Drug" (17 trials), "Device" (3 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Apixaban" (2 trials), "AGI-1067" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Louisiana Heart Center" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Louisiana Heart Center". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Louisiana Heart Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Louisiana Heart Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".